By-health Co Ltd
SZSE:300146
Intrinsic Value
By-health Co., Ltd. engages in the research, development, production, and sales of vitamin and dietary supplements. [ Read More ]
The intrinsic value of one By-health Co Ltd stock under the Base Case scenario is 24.21 CNY. Compared to the current market price of 15.56 CNY, By-health Co Ltd is Undervalued by 36%.
Valuation Backtest
By-health Co Ltd
Run backtest to discover the historical profit from buying and selling By-health Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
By-health Co Ltd
Current Assets | 8.3B |
Cash & Short-Term Investments | 6.4B |
Receivables | 597.4m |
Other Current Assets | 1.3B |
Non-Current Assets | 6.8B |
Long-Term Investments | 2.1B |
PP&E | 2.5B |
Intangibles | 1.9B |
Other Non-Current Assets | 286.7m |
Current Liabilities | 2.5B |
Accounts Payable | 426.6m |
Accrued Liabilities | 358.9m |
Other Current Liabilities | 1.7B |
Non-Current Liabilities | 468m |
Long-Term Debt | 161.5m |
Other Non-Current Liabilities | 306.5m |
Earnings Waterfall
By-health Co Ltd
Revenue
|
9.4B
CNY
|
Cost of Revenue
|
-2.9B
CNY
|
Gross Profit
|
6.5B
CNY
|
Operating Expenses
|
-4.5B
CNY
|
Operating Income
|
2B
CNY
|
Other Expenses
|
-231.6m
CNY
|
Net Income
|
1.7B
CNY
|
Free Cash Flow Analysis
By-health Co Ltd
Profitability Score
Profitability Due Diligence
By-health Co Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
Score
By-health Co Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
By-health Co Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.
Score
By-health Co Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
By-health Co Ltd
According to Wall Street analysts, the average 1-year price target for By-health Co Ltd is 23.45 CNY with a low forecast of 18.38 CNY and a high forecast of 32.55 CNY.
Shareholder Return
Price
By-health Co Ltd
Average Annual Return | 9.34% |
Standard Deviation of Annual Returns | 32.03% |
Max Drawdown | -59% |
Market Capitalization | 26.5B CNY |
Shares Outstanding | 1 700 822 631 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
By-health Co., Ltd. engages in the research, development, production, and sales of vitamin and dietary supplements. The company is headquartered in Guangzhou, Guangdong and currently employs 3,888 full-time employees. The company went IPO on 2010-12-15. The firm's main products include protein powders, vitamin C tablets, vitamin B tablets, natural vitamin E capsules, vitamin A and D soft capsules, calcium and vitamin D soft capsules, bovine colostrum calcium tablets, bone collagen calcium tablets, spirulina tablets, grape seed tablets, wheat germ oil soft capsules, deep-sea fish oil soft capsules, tuna oil soft capsules, propolis soft capsules, soybean phospholipids soft capsules and squalene soft capsules, among others. The firm distributes its products primarily in domestic market.
Contact
IPO
Employees
Officers
The intrinsic value of one By-health Co Ltd stock under the Base Case scenario is 24.21 CNY.
Compared to the current market price of 15.56 CNY, By-health Co Ltd is Undervalued by 36%.